Cardinal Partners β Full Portfolio
19 tracked investments Β· listed companies and verified rows first
aTyr is a clinical-stage biotechnology company developing therapies derived from tRNA synthetase biology to treat fibrosis and inflammation, with its lead candidate efzofitimod in clinical trials for interstitial lung disease.
BiotechHealthtechMedical DevicesSan Diego, US
Paul Schimmel(Non-Management Director)John D. Mendlein(Executive Officer, Director)David Weiner(Executive Officer)Frederic Chereau(Executive Officer)
BoardAmir Nashat(Non-Management Director)inAkkaraju Srinivas(Non-Management Director)
Board seatPaul SchimmelJohn ClarkeΒ· per SEC Form D
Co-investorsEcoR1 CapitalSofinnova VenturesDomain PartnersPolaris PartnersSamsara BioCapital
Teladoc Health operates a virtual care platform connecting patients with care providers for medical care, mental health, and chronic disease management services.
Digital HealthHealthtechMental HealthPurchase, US
Michael King(Executive Officer)Mark Hirschhorn(Executive Officer)Jason Gorevic(Executive Officer, Director)Kevin Williamson(Executive Officer)Adam Vandervoort(Executive Officer)Daniel Trencher(Executive Officer)
Board seatThomas G. McKinleyΒ· per SEC Form D
Co-investorsDria VenturesHarmonic Growth PartnersHLM Venture PartnersKleiner PerkinsNew Capital PartnersQuestMark Partners+2 more
Alkermes develops pharmaceutical medicines for psychiatric and neurological disorders, including addiction, serious mental illness, and sleep disorders.
BiotechHealthtechMedical Devices
PartnerJohn ClarkeΒ· led
Co-investorsHatteras Venture Partners
Privia Health operates a network of physician practices organized for value-based care delivery, supporting independent practices and physicians across multiple specialties while maintaining clinical autonomy.
Data & InfrastructureDigital HealthEnterprise SoftwareHealthtechSaaS
Verastem Oncology is a biopharmaceutical company that discovers and develops drugs to treat cancer patients.
BiotechMedical DevicesNeedham, US
Robert WeinbergRICHARD ALDRICH(Director)AMY C. CAVERS(Executive Officer)CATHY CAREW(Executive Officer)JONATHAN PACHTER(Executive Officer)ROB GAGNON(Executive Officer)
PartnerJohn ClarkeΒ· led
Co-investorsBessemer Venture PartnersForesite CapitalLightstone VenturesLongwood FundOberland CapitalOrbiMed
Palo Alto, US
Linda T. Hand(Executive Officer, Director)Niall O'Cathasaigh(Executive Officer)
BoardKent Marquardt(Director)Thomas McKinley(Director)Mark Smith(Director)Elizabeth Spaulding(Director)
Board seatJohn ClarkeΒ· per SEC Form D Β· $2M raise Β· filed Mar 2018
Co-investorsKleiner Perkins
Alnylam is a biopharmaceutical company that supports investigator-initiated studies in therapeutic areas including transthyretin-mediated amyloidosis, acute hepatic porphyria, and primary hyperoxaluria for medical researchers and healthcare professionals.
BiotechDigital HealthMedical Devices
John Maraganore(Founder)inDr. Yvonne Greenstreetin
Co-investorsARCH Venture PartnersAtlas VentureBlackstone Life Sciences
Cloud-based healthcare platform for clinical workflows
Bob Segertin
Co-investorsAspect VenturesBain Capital Double Impact Fund LPBain Capital Tech OpportunitiesBCIDraper AssociatesMercury Fund+6 more
New York, US
Joseph Mayer(Director)James Bradley(Director)Bharath Ganesan(Director)Richard Resnick(Executive Officer, Director)
BoardJohn Clarke(Director)inTodd Pietri(Director)
Co-investorsWindham Capital PartnersActivate Ventures
Ivenix makes an intelligent infusion pump system for hospital settings that delivers intravenous medications to patients while incorporating safeguards to reduce medication errors.
BiotechHealthtechMedical DevicesAmesbury, US
John Sokolowski(Executive Officer)George W. Gray(Executive Officer)Carolyn Malleck(Executive Officer)Jesse Ambrosina(Executive Officer)
BoardKetan Patel(Director)inJohn K. Clarke(Director)in
Co-investorsF-Prime CapitalSCP Vitalife PartnersECO Fleet Holdings
Life Image (now part of Intelerad, a GE HealthCare company) provides technology that connects physicians and moves medical imaging and data across the patient journey.
Digital HealthEnterprise SoftwareHealthtechMedical DevicesNewton, US
Hamid Tabatabaie(Executive Officer, Director, Promoter)
BoardDavid Jahns(Director)Thomas McKinley(Director)William Cowen(Director)in
Co-investorsLRVHealth
Prealize develops AI and machine learning solutions for healthcare providers and health plans to enable proactive, prediction-driven care rather than reactive treatment.
AI & Machine LearningDigital HealthHealthtechInsurTechStanford, US
BoardDr. Arnold MilsteinDr. Nigam Shah
Prexton Therapeutics was a biopharmaceutical company developing novel therapies for Parkinson's disease, including its lead mGluR4 modulator candidate foliglurax.
BiotechHealthtechMedical DevicesCopenhagen, DK
Co-investorsM VenturesSeroba Life SciencesSunstone CapitalYsios Capital
Vividion Therapeutics develops small molecule therapeutics using a covalent-first chemoproteomics approach to identify and target previously undruggable proteins.
AI & Machine LearningBiotechDeep TechPrinceton, US
Ben Cravatt(Scientific Founder)Phil Baran(Scientific Founder)Jin-Quan Yu(Scientific Founder)
BoardJohn Park(Executive Officer)John Clarke(Executive Officer, Director)in
Co-investorsARCH Venture PartnersAvoro Capital AdvisorsNextech InvestSoftBank Vision FundVersant Ventures
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.